FindTrial
Sign In

Dexavit

DRUG3 trials

Sponsors

Rigshospitalet

Conditions

Lung cancerPatients resuscitated from out-of-hospital cardiac arrestWe investigate the efficacy of two pharmaceutical interventions for reducing mortality and organ damageand shortening length of hospital stay in patients undergoing heart surgery (i.e. coronary artery bypass grafting and/or heart valve replacement).

Phase 2

High Dose Dexamethasone in High-Pain-Responders Undergoing Enhanced Recovery Video-Assisted Thoracoscopic Surgery Lobectomy and Segmentectomy – A Randomized Double-Blinded Controlled Trial
RecruitingCTIS2025-520891-25-00
RigshospitaletLung cancer
Start: 2025-08-28Target: 80Updated: 2025-07-14

Phase 3

DANOHCA: The Danish Out-of-Hospital Cardiac Arrest study
RecruitingCTIS2024-515997-28-00
RigshospitaletPatients resuscitated from out-of-hospital cardiac arrest
Start: 2023-06-16Target: 1000Updated: 2025-12-05
GLORIOUS II: Dexamethasone, olanzapine, flow-targeted versus pressure-targeted hemodynamic management, and low tidal volume ventilation in patients undergoing on-pump cardiac surgery – a multifactorial design randomized trial
RecruitingCTIS2024-515998-94-00
Rigshospitaletand shortening length of hospital stay in patients undergoing heart surgery (i.e. coronary artery bypass grafting and/or heart valve replacement)., We investigate the efficacy of two pharmaceutical interventions for reducing mortality and organ damage
Start: 2022-11-10Target: 1200Updated: 2024-10-23